Amarin Corp. Plc (AMRN)
13.80
-0.24
(-1.71%)
USD |
NASDAQ |
Sep 11, 16:00
13.80
0.00 (0.00%)
After-Hours: 16:29
Amarin Gross Profit (TTM) : 75.12M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.12M |
| March 31, 2026 | 110.99M |
| December 31, 2025 | 118.38M |
| September 30, 2025 | 85.74M |
| June 30, 2025 | 80.21M |
| March 31, 2025 | 72.02M |
| December 31, 2024 | 78.65M |
| September 30, 2024 | 133.64M |
| June 30, 2024 | 146.87M |
| March 31, 2024 | 146.89M |
| December 31, 2023 | 163.36M |
| September 30, 2023 | 181.89M |
| June 30, 2023 | 214.53M |
| March 31, 2023 | 214.94M |
| December 31, 2022 | 238.55M |
| September 30, 2022 | 288.45M |
| June 30, 2022 | 337.44M |
| March 31, 2022 | 416.27M |
| December 31, 2021 | 458.80M |
| September 30, 2021 | 478.68M |
| June 30, 2021 | 493.25M |
| March 31, 2021 | 478.21M |
| December 31, 2020 | 484.24M |
| September 30, 2020 | 464.96M |
| June 30, 2020 | 426.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 397.26M |
| December 31, 2019 | 334.07M |
| September 30, 2019 | 279.41M |
| June 30, 2019 | 234.88M |
| March 31, 2019 | 196.55M |
| December 31, 2018 | 173.30M |
| September 30, 2018 | 154.96M |
| June 30, 2018 | 148.76M |
| March 31, 2018 | 143.96M |
| December 31, 2017 | 135.75M |
| September 30, 2017 | 120.79M |
| June 30, 2017 | 107.51M |
| March 31, 2017 | 96.17M |
| December 31, 2016 | 88.38M |
| September 30, 2016 | 79.87M |
| June 30, 2016 | 71.41M |
| March 31, 2016 | 59.30M |
| December 31, 2015 | 51.43M |
| September 30, 2015 | 44.47M |
| June 30, 2015 | 39.35M |
| March 31, 2015 | 36.15M |
| December 31, 2014 | 33.48M |
| September 30, 2014 | 28.94M |
| June 30, 2014 | 25.03M |
| March 31, 2014 | 19.93M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 3.289B |
| Alkermes Plc | 1.370B |
| DBV Technologies SA | -12.78M |
| Cellectis SA | 37.38M |
| Akari Therapeutics Plc | 0.00 |